NYSE · Drug Manufacturers - General

Bristol-Myers Squibb Company Ce (CELG-RI) Stock

$0.12 -0.08% NYSE: CELG-RI Healthcare

Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies.

Valuation

MetricValue
Price$0.12
Market Cap$241.78M
P/E Ratio0.02
P/B Ratio0.04
P/S Ratio0.02
EPS (TTM)$5.51
52-Week High$0.12
52-Week Low$0.09
Dividend Yield—

Financials & Margins

MetricValue
ROE61.86%
ROA11.40%
ROCE16.52%
Gross Margin96.16%
Operating Margin33.97%
Net Margin26.48%
Debt/Equity3.29
Current Ratio2.23

Annual Financials (USD)

Metric20142015201620172018
Revenue$7.7B$9.3B$11.2B$13.0B$15.3B
Operating Profit$2.5B$2.3B$3.2B$4.7B$5.2B
Net Profit$2.0B$1.6B$2.0B$2.9B$4.0B
EPS$2.39$1.94$2.49$3.64$5.51
Op Margin32.8%24.4%28.2%36.2%34.0%

Balance Sheet (USD)

Metric20142015201620172018
Total Assets$17.3B$27.1B$28.1B$30.1B$35.5B
Total Liabilities$10.8B$21.1B$21.5B$23.2B$29.3B
Cash$4.1B$4.9B$6.2B$7.0B$4.2B
Borrowings$6.9B$14.3B$14.3B$15.8B$20.3B

Latest News

Building Canada strong by investing in water and wastewater infrastructure to support housing growth CNW Group · Jul 16, 2026 Toyota, BMW, Bosch, Repsol trial renewable petrol in Spain Just Auto · Jul 16, 2026 AAIC26: Roche charts expanded course for Alzheimer’s therapy, touts long-term anti-amyloid impact Clinical Trials Arena · Jul 16, 2026 Postal operators struggle to break even despite parcel growth FreightWaves · Jul 16, 2026 IBD Live Q&A Summary, Stock Lists For Thursday, July 16, 2026 Investor's Business Daily · Jul 16, 2026

Cash Flow (USD)

Metric20142015201620172018
Operating Cash Flow$2.8B$2.5B$4.0B$5.2B$5.2B
Investing Cash Flow$-1.6B$-6.5B$-1.2B$-3.2B$-6.7B
Financing Cash Flow$-3.4B$1.3B$-3.8B$-5.4B$-7.6B
Net Cash Flow$888.0M$759.0M$1.3B$843.0M$-2.8B
Free Cash Flow$2.7B$2.2B$3.7B$5.0B$4.8B

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA2.79
FCF Yield2002.22%
Quick Ratio2.12
Interest Coverage7.01
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMGNAmgen Inc. $387.64 -1.39% 23.42 $209.21B 2.82%
CVSCVS Health Corp. $105.92 -3.13% 44.16 $135.15B 2.64%
GILDGilead Sciences, Inc. $132.73 -1.18% 17.57 $164.79B 2.46%
GSKGSK plc $51.58 — 9.28 $103.73B 3.49%
HCAHCA Healthcare, Inc. $408.18 -2.39% 13.62 $90.55B 0.76%

About Bristol-Myers Squibb Company Ce

Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.

Bristol-Myers Squibb Company Ce is headquartered in US.

Bristol-Myers Squibb Company Ce (CELG-RI) stock trades at $0.12 with a market capitalization of $241.78M. The stock is valued at a price-to-earnings (P/E) ratio of 0.02, price-to-book of 0.04, price-to-sales of 0.02. Over the past 52 weeks the stock has ranged between $0.09 and $0.12, and currently trades at its 52-week high.

On profitability, Bristol-Myers Squibb Company Ce generates a return on equity (ROE) of 61.86% — well above the market average, a sign of a high-quality business, return on capital employed of 16.52%, an operating margin of 33.97%, a net profit margin of 26.48%.

Official website: www.bms.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides